NHS Herefordshire Clinical Commissioning Group
Wye Valley NHS Trust

 
back
13 Skin

Emollient Prescribing Guidance (Herefordshire) 2019

13-05-03 Drugs affecting the immune response

Adalimumab Humira®
Restricted

Injectable preparation not suitable for primary care prescribing

 

Link  NICE TA392: Adalimumab for treating moderate to severe hidradenitis suppurativa
 

Restricted Drug Red View adult BNF  View SPC online  View childrens BNF  HCD
Apremilast Otezla®
Restricted

For active psoriatic arthritis in line with TA433


Restricted Drug Red View adult BNF  View SPC online  View childrens BNF  HCD
Apremilast Otezla®
Restricted

For active psoriatic arthritis in line with TA433

Link  NICE TA372: Apremilast for psoriatic arthritis
Link  NICE TA419: Apremilast for treating moderate to severe plaque psoriasis
Link  NICE TA433 : Apremilast for treating active psoriatic arthritis
 

Restricted Drug Red View adult BNF  View SPC online  View childrens BNF  HCD
Ciclosporin
Restricted

See specialist information


Restricted Drug Amber View adult BNF  View SPC online  View childrens BNF
Etanercept Enbrel®
Restricted

Injectable preparation not suitable for primary care prescribing

Link  NICE TA103: Psoriasis - efalizumab and etanercept
 

Restricted Drug Red View adult BNF  View SPC online  View childrens BNF  HCD
Infliximab Remicade®
Restricted

As per NICE. Consultant Dermatologist prescribing only 

Link  NICE TA134: Infliximab for psoriasis
 

Restricted Drug Red View adult BNF  View SPC online  View childrens BNF  HCD
Methotrexate
Restricted

Dermatology - see shared care

 

 


Restricted Drug Cytotoxic Drug  Amber View adult BNF  View SPC online  View childrens BNF
Pimecrolimus Elidel®
Formulary

In Line With NICE TA82
On recommendation of Dermatology Specialist only. GPs may issue first prescription

Link  NICE TA82: Pimecrolimus and tacrolimus for atopic dermatitis (eczema)
 

Green View adult BNF  View SPC online  View childrens BNF
Secukinumab Cosentyx®
Restricted

In line with NICE technology appraisals and local guidance

Link  NICE TA350: Plaque Psoriasis
Link  NICE TA407: Secukinumab for active ankylosing spondylitis after treatment with non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors
 

Restricted Drug Red View adult BNF  View SPC online  View childrens BNF  HCD
Tacrolimus Protopic®
Formulary

In Line With NICE TA82
On recommendation of Dermatology Specialist only. GPs may issue first prescription. 

Link  NICE TA82: Pimecrolimus and tacrolimus for atopic dermatitis (eczema)
 

Green View adult BNF  View SPC online  View childrens BNF
Ustekinumab
Restricted

In line with NICE technology appraisals and local guidance

Link  NICE TA180: Psoriasis - ustekinumab
Link  NICE TA340: Ustekinumab for treating active psoriatic arthritis
Link  NICE TA455 : Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young peopl
Link  NICE TA456 : Ustekinumab for moderately to severely active Crohn’s disease after previous treatment
 

Restricted Drug Red View adult BNF  View SPC online  View childrens BNF  HCD
Azathioprine
Non Formulary

Cytotoxic Drug  View adult BNF  View SPC online  View childrens BNF
Efalizumab Raptiva®
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Guselkumab
Non Formulary
Link  NICE TA521 : Guselkumab for treating moderate to severe plaque psoriasis
 

View adult BNF  View SPC online  View childrens BNF
Hydroxychloroquine
Non Formulary

View adult BNF  View SPC online  View childrens BNF